Sinotherapeutics Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	47.48	127.7	61.07	92.93	134.92
Depreciation & Amortization	31.9	18.36	23.27	26.43	26.94
Other Amortization	0.49	7.09	0.78	1.54	1.84
Loss (Gain) From Sale of Assets	-	-	-0.08	-0.16	0.02
Asset Writedown & Restructuring Costs	16.56	-1.03	1.72	-2.55	1.04
Loss (Gain) From Sale of Investments	-9.29	-11	-9.61	-20.79	-3.9
Stock-Based Compensation	-	-	-	-	7.94
Provision & Write-off of Bad Debts	-	3.93	0.81	1.43	-0.29
Other Operating Activities	4.73	-2.06	-1.22	-5.31	4.25
Change in Accounts Receivable	22.89	-25.28	-2.18	-42.77	-6.61
Change in Inventory	14.43	-16.46	-56.47	13.83	-0.05
Change in Accounts Payable	-17.75	17.53	-4.11	12.6	-52.23
Change in Other Net Operating Assets	-16.29	16.63	-3.03	-3.5	33.69
Operating Cash Flow	95.33	130.23	12.96	73.18	145.77
Operating Cash Flow Growth	-26.80%	905.01%	-82.29%	-49.80%	-30.60%
Capital Expenditures	-41.56	-94.93	-38.96	-176.34	-16.01
Cash Acquisitions	-	-	-	-10.85	-
Investment in Securities	148.9	-399.89	-84.41	-20	-52.6
Other Investing Activities	9.64	10.98	15.79	6.88	4.38
Investing Cash Flow	116.98	-483.84	-107.57	-200.31	-64.23
Long-Term Debt Repaid	-	-0.07	-0.16	-0.92	-0.93
Net Debt Issued (Repaid)	-	-0.07	-0.16	-0.92	-0.93
Issuance of Common Stock	-	-	-	389.93	-
Repurchase of Common Stock	-	-36.15	-	-	-
Common Dividends Paid	-27.84	-27.88	-28.11	-	-
Other Financing Activities	-0.07	-	-	-13.36	-
Financing Cash Flow	-27.91	-64.09	-28.27	375.65	-0.93
Foreign Exchange Rate Adjustments	-3.29	1.71	1.52	2.97	-2.9
Net Cash Flow	181.1	-416	-121.36	251.5	77.71
Free Cash Flow	53.77	35.3	-26	-103.15	129.77
Free Cash Flow Growth	52.32%	-	-	-	-24.42%
Free Cash Flow Margin	12.04%	6.90%	-8.67%	-41.67%	41.13%
Free Cash Flow Per Share	0.13	0.08	-0.06	-0.24	0.32
Cash Income Tax Paid	20.01	5.13	1.28	9.17	1.1
Levered Free Cash Flow	63.41	-22.06	-42.85	-150.44	30.86
Unlevered Free Cash Flow	63.41	-22.06	-42.82	-150.31	31.01
Change in Working Capital	3.45	-12.76	-63.78	-20.34	-26.98

Source: S&P Global Market Intelligence. Standard template. Financial Sources.